Dr. Vincent Chung, MD
Claim this profileCity of Hope Medical Center
About Vincent Chung, MD
Education:
- Earned an MD from the University of Tennessee Health Science Center College of Medicine, class of 1998.
Experience:
- Completed an Internship and Residency in Internal Medicine at California Pacific Medical Center.
- Undertook a Fellowship in Hematology and Medical Oncology at Los Angeles County-Harbor-UCLA Medical Center.
- Served as Chief Resident at California Pacific Medical Center.
- Board-certified in Internal Medicine and Medical Oncology.
- Affiliated with City of Hope's Helford Clinical Research Hospital, specializing in Medical Oncology.
Area of expertise
Pancreatic Cancer
Vincent Chung, MD has run 14 trials for Pancreatic Cancer. Some of their research focus areas include:
Cancer
Vincent Chung, MD has run 5 trials for Cancer. Some of their research focus areas include:
Affiliated Hospitals
City Of Hope Medical Center
City Of Hope
Clinical Trials Vincent Chung, MD is currently running
Gemcitabine + Leflunomide
for Pancreatic Cancer
This phase Ib trial tests the safety, side effects, and best dose of leflunomide in combination with gemcitabine in treating patients with pancreatic cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) and cannot be removed by surgery (unresectable). Improving the effectiveness of gemcitabine without increasing side effects could lead to a greater impact for pancreatic cancer patients' survival and quality of life. Gemcitabine is commonly used as a first-line chemotherapy treatment for pancreatic cancer. Leflunomide is a drug approved for use against rheumatoid arthritis that is being looked at as a cancer treatment option. It has shown promising results when combined with gemcitabine. Giving gemcitabine in combination with leflunomide may be safe and effective in treating patients with advanced unresectable pancreatic cancer.
Recruiting
1 award
Phase 1
8 criteria
Peposertib + Radiation Therapy
for Pancreatic Cancer
This phase I/II trial studies the safety, side effects and best dose of M3814 and to see how well it works when given together with radiation therapy in treating patients with pancreatic cancer that has spread to nearby tissue or lymph nodes (locally advanced). M3814 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Hypofractionated radiation therapy delivers higher doses of radiation therapy over a shorter period of time and may kill more tumor cells and have fewer side effects. Giving M3814 and hypofractionated radiation therapy together may be safe, tolerable and/or more effective than radiation therapy alone in treating patients with locally advanced pancreatic cancer.
Recruiting
0 awards
Phase 1 & 2
3 criteria
More about Vincent Chung, MD
Clinical Trial Related
3 years of experience running clinical trials · Led 21 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Vincent Chung, MD has experience with
- Pembrolizumab
- Lenvatinib Mesylate
- Gemcitabine Hydrochloride
- Nivolumab
- Ipilimumab
- Gemcitabine
Breakdown of trials Vincent Chung, MD has run
Pancreatic Cancer
Cancer
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Vincent Chung, MD specialize in?
Vincent Chung, MD focuses on Pancreatic Cancer and Cancer. In particular, much of their work with Pancreatic Cancer has involved Stage IV patients, or patients who are ctDNA positive.
Is Vincent Chung, MD currently recruiting for clinical trials?
Yes, Vincent Chung, MD is currently recruiting for 4 clinical trials in Duarte California. If you're interested in participating, you should apply.
Are there any treatments that Vincent Chung, MD has studied deeply?
Yes, Vincent Chung, MD has studied treatments such as Pembrolizumab, Lenvatinib Mesylate, Gemcitabine Hydrochloride.
What is the best way to schedule an appointment with Vincent Chung, MD?
Apply for one of the trials that Vincent Chung, MD is conducting.
What is the office address of Vincent Chung, MD?
The office of Vincent Chung, MD is located at: City of Hope Medical Center, Duarte, California 91010 United States. This is the address for their practice at the City of Hope Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.